Report Finder

All Sentinel reports, surveillance tools, FDA assessments, and communication materials may be searched using the options below. Search results can be further sorted by title, project status, and date posted by clicking on the relevant column header. If you wish to search for FDA Center assessments more specifically by medical product and health outcome, please go to the CDER Assessments and CBER Assessments pages.

E.g., 6/25/2019
E.g., 6/25/2019
Title Status FDA Center Date Postedsort ascending
Combined Oral Contraceptives Containing Ethinyl Estradiol and Levonorgestrel and Venous Thromboembolism Complete CDER 03/04/2018
Venous Thromboembolism following Continuous or Extended Cycle Contraceptive Use: A Propensity Score Matched Analysis Complete CDER 03/04/2018
Counts, Prevalence, and Incidence of Intravenous (IV) Iron Products In progress CDER 03/02/2018
Exposure to Intravenous (IV) Iron Procedures and Anaphylaxis and Epinephrine Events Complete CDER 03/02/2018
Rhabdomyolysis and/or Creatine Kinase Laboratory Results Following New Use of Statins or Angiotensin-Converting Enzyme Inhibitors Complete CDER 03/01/2018
Use of Tyrosine Kinase Inhibitors (TKIs) Complete CDER 02/28/2018
Length of Follow-up Time for New Users of Immunosuppressive Drugs Complete CDER 02/28/2018
Prevalent and Incident Dispensings of Ranolazine In progress CDER 02/26/2018
Testing Routine Querying Tools with Known Positive Exposure-Outcome Associations: Gastrointestinal (GI) Bleeding Following New Use of Warfarin Compared with Statins Complete 02/23/2018
Validation of Lymphoma in ICD-10-CM In progress 02/22/2018
Developing Capacity for “Surveillance of Prescribing Behaviors” Analyses in Sentinel, with Dronedarone and ECGs as a Use Case Complete 02/12/2018
Sinus Stents with Mometasone and Diminished Visual Acuity Complete CDER 02/05/2018
Boceprevir, Ledipasivir/Sofosbuvir, Simeprevir Sodium, Sofosbuvir, and Telaprevir Use In progress CDER 02/05/2018
Metabolic Effects of Second Generation Antipsychotics in Youth, Subprojects 1, 2, and 3 Complete CDER 02/01/2018
Prevalent and Incident Use of SGLT2 Inhibitors In progress CDER 02/01/2018
Concomitant Use of Opioid Analgesics and Cytochrome P450 (CYP) Inhibitors and Inducers Complete CDER 02/01/2018
Antiepileptic Drug (AED) Injection Procedure Codes Complete CDER 01/31/2018
PROMPT: Rivaroxaban Surveillance Complete CDER 01/31/2018
Counts of Commonly used Angiostensin-Converting Enzyme (ACE) Inhibitors and Beta Blockers In progress CDER 01/29/2018
Drug and Medical Enrollment Counts Complete CDER 01/29/2018
A Protocol for Assessment of Dabigatran and Selected Safety Outcomes Complete CDER 01/26/2018
Influenza Vaccines and Pregnancy Outcomes (PRISM) Complete CBER 01/26/2018
Use of Tumor Necrosis Factor (TNF) Blocker Drugs In progress CDER 01/26/2018
Conversion of Medicare Claims Synthetic Public Use Files (SynPUFs) to Sentinel Common Data Model (SCDM) Format Complete 01/25/2018
Characterization of Pediatric Medical Conditions: Respiratory Syncytial Virus (RSV) Associated Illness Complete CDER 01/25/2018
Molecularly Targeted Anti-Cancer Therapies Complete CDER 01/24/2018
Use of Stents Complete CDRH 01/23/2018
Stroke Diagnosis Codes Complete CDER 01/18/2018
Length of Enrollment in Pediatric Population Complete CDER 01/17/2018
Prevalent and Incident Use of Isotretinoin In progress CDER 01/16/2018
Occurrence of Selected Generic Drugs 13 Complete CDER 01/11/2018
Clostridium Difficile Prevalence and Vancomycin, Fidaxomicin, and Tocilizumab Use Complete CDER 01/08/2018
Use of Dronedarone HCL In progress CDER 01/08/2018
Incident and Prevalent Dispensings of Mirabegron In progress CDER 01/01/2018
Methotrexate Medication Errors Complete 12/31/2017
Use of Ospemifene, Boceprevir, and Telaprevir In progress CDER 12/29/2017
Postlicensure Medical Product Safety Data-Mining: Power Calculations for Bernoulli Data Complete CBER 12/22/2017
TreeScan Extension (PRISM) Complete 12/22/2017
Prevalent and Incident Use of Testosterone Products In progress CDER 12/21/2017
Top 100 Procedures and Diagnoses 30 Days Surrounding Incident Warfarin Use Complete CDER 12/21/2017
Anti-Tumor Necrosis Factor (TNF) Utilization Among Pregnant Women Complete CDER 12/20/2017
Prevalent and Incident Use of Romiplostim In progress CDER 12/18/2017
Suicide Diagnoses Complete CDER 12/15/2017
Trends in Fibroid Surgery and Use of Power Morcellation Complete CDRH 12/14/2017
Incident and Prevalent Use of Generic Drugs for Overactive Bladder In progress CDER 12/11/2017
Use of Cancer Drugs In progress CDER 12/08/2017
Antipsychotic Use and Dementia Diagnoses In progress CDER 12/07/2017
Genetic Testing Procedures Complete CDER 12/05/2017
Atrial Fibrillation Prevalence Complete CDER 12/04/2017
Mycophenolate Dispensings and Procedures (by Quarter) Complete CDER 12/01/2017
Mycophenolate Dispensings and Procedures In progress CDER 12/01/2017
Development of Metrics to Assess Appropriate Prescribing of Opioids in the Mini-Sentinel Distributed Database (MSDD) Complete 11/20/2017
Validation of Serious Infections among an Immunocompromised Population In progress 11/19/2017
Influenza Vaccines and Febrile Seizures in the 2013-2014 and 2014-2015 Influenza Seasons Complete CBER 11/10/2017
Niacin and Fenofibrate Use and Outcomes with Propensity Score Matching Complete CDER 11/06/2017
Stroke following Typical or Atypical Antipsychotic Use in Non-Elderly Patients: A Propensity Score Matched Analysis Complete CDER 11/02/2017
Stroke following Atypical Antipsychotic or Z-Hypnotic Use in Patients with Prior Use of Selective Serotonin Reuptake Inhibitors (SSRIs): A Propensity Score Matched Analysis Complete CDER 11/02/2017
Antipsychotics and Stroke Complete CDER 11/01/2017
Sodium/Glucose Cotransporter (SGLT2) Inhibitors- Type 1 and Type 2 Diabetes Cohort Identification Complete CDER 10/30/2017
Niacin and Niacin Combination Products, Fenofibrates, and Omega-3 Products In progress CDER 10/12/2017
Alosetron Use In progress CDER 10/11/2017
Mirabegron Use In progress CDER 10/11/2017
Counts and Prevalence of 50 Venous Thromboembolism (VTE) Diagnosis Codes Complete CBER 10/09/2017
Pegylated Products Use In progress CDER 10/06/2017
Pegylated Products Follow-Up Request Complete CDER 10/06/2017
New Molecular Entities In progress CDER 10/04/2017
Indications of Use Among Oral Antifungal Drug Users Complete CDER 09/01/2017
Inverse Probability of Treatment Weighting Functional Specifications and Prototype Development In progress 08/24/2017
The Use of Propensity Score Matching for Estimating Hazard Ratios in Post-Market Surveillance with Heavy Censoring In progress 08/18/2017
Evaluating Variability with 1:1 Propensity Score-Matched Analyses Complete 08/18/2017
Death Data Exploration Complete 08/17/2017
Evaluation of New Technologies Associated with Chart Review Complete 08/16/2017
Quantitative Bias Analysis Methodology Development Complete 08/04/2017
Pertussis Cases in Infants Complete CBER 07/27/2017
Tdap Vaccination During Pregnancy Complete CBER 07/27/2017